王婷，女，博士，副教授，硕士生导师

1998/09–2002/07， 兰州大学， 学士

2002/09–2007/07， 兰州大学， 博士

2007/07-2008/03，郑州大学，任教

2008/3-2008/12，美国纽约血液中心，博士后

2008/12-2013/03，美国国家脐带血项目临床研究所, 研究专员

2013/03-至今，郑州大学，任教

联系方式： tingwang@zzu.edu.cn

研究方向：主要从事肿瘤免疫调节及分子机制的研究

主持及参与项目：

1．国家自然科学基金青年基金项目：4.1N基因调控EMT在结肠癌转移中的作用及分子机制研究, 主持

2．河南省高等学校重点科研项目计划：基于4.1N基因差异表达的结肠癌诊断新方法研究,主持

3．十二五新药创制国家科技重大专项子课题：候选Th1免疫增强新药rMBP-NAP抗肿瘤研究，参加

4．重大研究计划培育项目：乳腺肺转移的区域免疫特性与共抑制分子拮抗肽干预研究，参加

近期发表论文：

1. Ting Wang,*, Siwei Chen,*, Shihui Wang, Liang Shi, Chenggong Wang, Jingxin Zhang, Yanfeng Gao, Guodong Li, Yuanming Qi, Xiuli An, Lixiang Chen. Targeting neurokinin-3 receptor: a novel anti-angiogenesis strategy for cancer treatment. Oncotarget. 2017,8(25):40713-40723.

2. Lixiang Chen*, Ting Wang*, Yaomei Wang, Jingxin Zhang, Yuanming Qi, Haibo Weng, Qiaozhen Kang, Xinhua Guo, Anthony J. Baines, Narla Mohandas, Xiuli An. Protein 4.1G Regulates Cell Adhesion, Spreading and Migration of Mouse Embryo Fibroblasts through β1 Integrin Pathway. The Journal of Biological Chemistry. (2016) 291(5): 2170-2180.

3. Xin Liu, Guo Fu, ZhenyuJi, Xiabing Huang, Cong Ding, Hui Jiang, Xiaolong Wang, Mingxuan Du, Ting Wang*, Qiaozhen Kang*, A recombinant DNA Plasmid encoding the sIL-4R-NAP fusion protein suppress airway inflammation in an OVA-induced mouse model of asthma, Inflammation, 2016

4. Ting Wang, Xilong Liu, ZhenyuJi, Yingli Men, Mingxuan Du, CongDing, Yahong Wu, Xin Liu*, Qiaozhen Kang*, Antitumor and immunomodulatory effects of recombinant fusion protein rMBP-NAP through TLR-2 dependent mechanism in tumor-bearing mice, International Immunopharmacology, 2015, 29(2): 876-883.

5. XinLiu, Qingqing Zhou, ZhenyuJi, Guo Fu, Yi Li, Xiaobei Zhang, Xiaofang Shi, Ting Wang*, Qiaozhen Kang*, Protein 4.1R attenuatesautoreactivity in experimental autoimmune encephalomyelitis by suppressing CD4 +T cell activation, Cellular Immunology, 2014, 292: 19-24.

6. Ting Wang, Li-Xiang Chen, Yuan Long, Wei-Min Wua, Rui Wang. DNA damage induced by caffeic acid phenyl ester in the presence of Cu(II) ions: potential mechanism of its anticancer properties. Cancer Letters. (2008) 263(1): 77-88.

专利：

(1) 刘鑫，康巧珍，傅国，汲振余，王婷，曲晓利，王小龙，杜明宣，sIL-4R-NAP融合基因，2016，中国，ZL201410161397.2